StockData
SI-BONE, Inc. logo

SI-BONE, Inc. (SIBN) income statement

SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3046% above fair value
$23.54+0.38 (+1.64%)

Close on Nov 18, 2026Market cap $1.06BP/E –Yield 0.00%

SI-BONE, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
79.5%
Operating margin
-8.3%
Net margin
-6.9%
Return on equity, FY2025
-11.0%

Financial strength

Current ratio
9.15
Debt to equity
0.20
Debt to assets
14.3%
Cash to current liabilities
137.8%

Valuation

P/E ratio
–
Price to sales
4.94
Price to book
5.79
Dividend yield
0.00%

See a number that looks wrong?